These 3D printed implants were used to heal severe spinal cord injury in rat...
These 3D printed implants were used to heal severe spinal cord injury in rat models.
Source: University of California San Diego

Bioprinting nanoparticles for ovarian cancer immunotherapy

Nanoengineers at UC San Diego received a five-year, $2.9 million grant from the National Institutes of Health to develop an immunotherapy for ovarian cancer using plant virus nanoparticles. The particles will be produced using 3D-bioprinting, enabling them to be released at specified intervals, instead of a continuous slow release.

High grade serous ovarian cancer (HGSOC) is the most common and severe form of ovarian cancer, accounting for an estimated 70 percent of all ovarian cancer diagnoses. To provide an effective and long lasting treatment for HGSOC, Professor Nicole Steinmetz plans to use a patient’s own irradiated tumor cells, coupled with a virus-like particle (VLP) from a plant virus that has been shown to boost the body’s immune response, to trigger the body to attack the tumor cells. The irradiated tumor cells will serve as the foreign agent telling the body’s immune response exactly what cells to attack. The co-released VLP will boost the natural immune response in reaction to these tumor cells. This is meant to create a cellular memory against these tumor antigens, creating a long-lasting and adaptive anti-tumor immunity and preventing relapse.

“We have already demonstrated that our VLP nanotechnology is highly effective as a cancer immunotherapy,” said Steinmetz. “The innovation here lies in the advanced manufacturing coupled with the novel nanotechnology to produce a personalized immunotherapy to protect women with ovarian cancer from recurrence of this disease.”

Steinmetz’ team developed the VLP nanotechnology from the same non-infectious, non-toxic plant virus they used to successfully treat melanoma in dogs, and has shown that these plant virus-like particles generate anti-tumor immunity in mice with ovarian cancer.

The biopolymer immunotherapy will be delivered via an implant, produced using a 3D bioprinting technique developed in Professor Shaochen Chen’s 3D Bioprinting lab at the Jacobs School of Engineering. Known as rapid, microscale, continuous optical bioprinting, Chen’s team has used this 3D bioprinting method to create a spinal cord implant that could be used to promote nerve growth and treat spinal cord injury, as well as life-like liver tissue and intricate blood vessel networks. His lab will collaborate with Steinmetz to bioprint these immunotherapy implants incorporating the nanoparticles and irradiated tumor cells.

“Our 3D bioprinting platform enables manufacturing of patient specific implants with precise control over both the topographical complexity and the cellular and material composition,” said Chen. “The engineering design space and tunability of this approach is impeccable; in particular the implant will be designed so that therapeutic doses are released in programmed intervals.”

Ultimately, the researchers envision this immunotherapy implant being seamlessly added in to the existing ovarian cancer treatment process. During surgery to remove the bulk of the tumor, the biocompatible, biodegradable implant would be inserted in the cavity lining the patient’s abdomen, where it would release the engineered immunotherapy particles at timed intervals.

Subscribe to our newsletter

Related articles

On the path to safe nanomedicine

On the path to safe nanomedicine

Scientists have now developed guidelines that should enable the safe development of nanoparticles for medical use.

Melanoma: patch may be a treatment option

Melanoma: patch may be a treatment option

Scientists at Purdue University have developed a skin patch that can deliver chemotherapy into melanoma tumors in an effective and painless way.

Bioprinting tissues directly within the body

Bioprinting tissues directly within the body

Researchers take a step closer to 3D printing living tissues in patients as they develop a specially-formulated bio-ink designed for printing directly in the body.

Lung cancer: AI could predict risk of recurrence

Lung cancer: AI could predict risk of recurrence

Computer scientists working with pathologists have trained an AI tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.

AI model accurately classifies colorectal polyps

AI model accurately classifies colorectal polyps

An AI model for automated classification of colorectal polyps could benefit cancer screening programs by improving efficiency, reproducibility, and accuracy.

3D printed implants seed multiple layers of tissue

3D printed implants seed multiple layers of tissue

Researchers are 3D printing "groovy" tissue-engineering scaffolds with living cells to help heal injuries.

Bioengineering living heart valves

Bioengineering living heart valves

Reserchers have made progress developing living heart valves that can grow with the body and integrate with the patient's native tissue.

Smart algorithm finds possible future treatment for childhood cancer

Smart algorithm finds possible future treatment for childhood cancer

Using a computer algorithm, scientists at Uppsala University have identified a promising new treatment for neuroblastoma.

AI tracks down acute myeloid leukemia

AI tracks down acute myeloid leukemia

Artificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reliability.

Popular articles